ARCHIMEDlife (ARCHIMED Life Science GmbH)

Explicyte is a family brand of specialty preclinical services launched by ImmuSmol, a bordeaux-based company. The first brand, Explicyte Immune-Oncology offers preclinical contract research services in immuno-oncology.

Explicyte Immuno-Oncology currently offers to test innovative cancer immunotherapies in vivo, using syngeneic mouse tumor models treated with immune checkpoint inhibitors (eg. anti-CTLA-4 and anti-PD1/PD-L1 antibodies). In addition, Explicyte is setting up an in vitro platform for the identification and optimization of novel immunomodulators. Equipped with high-content analysis technologies, the platform focuses on live phenotypic screening in co-cultures of immune and cancer cells, as well as molecular cell-based assays for the assessment of immune checkpoint inhibitors.

Glycotope, founded in Berlin in 2000, is a clinical stage immuno-oncology company built on world-leading glycobiology expertise.
A set of our highly innovative clinical and pre-clinical projects with focus on oncology/immuno-oncology are available for partnering.
The Company has a mature and growing pipeline of proprietary cancer therapies. Our innovative GlycoExpress® technology enables the generation of high quality oncology and non-oncology candidates with fully human glycosylation improving activity, drug characteristics and side effect profiles. The GlycoBody platform generates highly specific mAbs against carbohydrate epitopes found only on tumor cells.

In addition, our capabilities in early-stage research and development provide a wide range of services for biopharmaceutical companies incl. glycan analytics (N- and O-glycans) as well as a whole range of protein analytics, USP and DSP process development, assay development in immune oncology as well as clinical immunomonitoring (http://www.glycotope.com/biopharmaceuticals-services/).

PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase.

We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area.

Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, Metabolic disorders, cardiovascular respiratory diseases). Our technology has a wide range of Applications from fundamental and discovery research to clinical development of therapeutic and diagnostic biomarkers.

Our patented technology stands out in allowing scientists in industry and academia to measure enzyme activity within a cellular context and fully decorated proteins. The assays have high sensitivity, broad kinome coverage and works for many sample sources.

PamGene has a strong science foundation and the number of publications applying our technology continues to rise. PamGene's Customer Service team supports your research with dedication. The PamAcademy offers advanced training, from workflows to data analysis, interpretation and storage. PamGene's PamCloud space allows User-interaction and furthers knowledge exploration.

Please visit our web site for further information (https://www.pamgene.com/) and get in touch with us! (https://www.pamgene.com/en/landing.htm)

Cerba Research is the merge of Barc Lab, Histalim and Cerba Xpert. All 3 entities are part of the Cerba HealthCare group and have decided to join forces under one name.

Cerba Research provides the highest quality specialized laboratory and diagnostic solutions while leveraging patient data and scientific insight to shape and advance clinical trials. With our global footprint and access to leading regional labs, data, patients, technology, and partnered resources, we support global biotech, pharma, and IVD organizations to improve the lives of patients around the world.

From the translation of preclinical to clinical, through commercialization, our expert scientists collaborate with you to optimize your therapeutic development and obtain critical insights earlier. We help accelerate your therapies through the development of highly specialized custom assays, deep biomarker expertise, and a passion for scientific innovation across complex therapeutic areas. Our global network of leading, specialty laboratories ensures you have access to quality data and can reach your patients. Together, we’ll improve patients’ lives around the globe.

Cmed is an innovative, full service, technology-led CRO, established in 2000 by a team of experts passionate about helping customers deliver highly successful clinical trials. We bring together an experienced team and our own innovative technology to drive real progress throughout the clinical trial process – for every step, every solution, every study. Our vision is to conduct clinical trials better than anyone else to help patients and ultimately save lives.

We have earned a strong reputation for successfully delivering complex, demanding and innovative clinical trials in various therapeutic areas, with specialist therapeutic expertise in oncology, cell & gene therapy, rare disease and in data & analytics.

Further information about Cmed’s full suite of services is available at www.cmedresearch.com.

To see the latest career opportunities at Cmed, visit www.cmedresearch.com/openpositions